Browsing by Author De Souza, C

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 1 to 5 of 5
PreviewIssue DateTitleAuthor(s)AdvisorType
2013Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phaseHochhaus, A; Saglio, G; Larson, RA; Kim, DW; Etienne, G; Rosti, G; De Souza, C; Kurokawa, M; Kalaycio, ME; Hoenekopp, A; Fan, XL; Shou, YP; Kantarjian, HM; Hughes, TP-Artigo de periódico
2000VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study GroupSantini, G; Coser, P; Congiu, AM; Salvagno, L; De Souza, C; Sertoli, MR; Olivieri, A; Chisesi, T; Rubagotti, A; Truini, M; Contu, A; Porcellini, A; Zambaldi, G; Nati, S; Marino, G; Rizzoli, V-Artigo de periódico
2005Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSGOlivieri, A; Santini, G; Patti, C; Chisesi, T; De Souza, C; Rubagotti, A; Aversa, S; Billio, A; Porcellini, A; Candela, M; Centurioni, R; Congiu, AM; Brunori, M; Nati, S; Spriano, M; Vimercati, R; Marino, G; Contu, A; Tedeschi, L; Majolino, I; Crugnola, M; Sertoli, MR-Artigo de periódico
2010Phase III, Randomized, Open-Label Study of Daily Imatinib Mesylate 400 mg Versus 800 mg in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase Using Molecular End Points: Tyrosine Kinase Inhibitor Optimization and Selectivity StudyCortes, JE; Baccarani, M; Guilhot, F; Druker, BJ; Branford, S; Kim, DW; Pane, F; Pasquini, R; Goldberg, SL; Kalaycio, M; Moiraghi, B; Rowe, JM; Tothova, E; De Souza, C; Rudoltz, M; Yu, R; Krahnke, T; Kantarjian, HM; Radich, JP; Hughes, TP-Artigo de periódico
2004A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma - Report from the Italian Non-Hodgkin's Lymphoma Co-operative Study GroupSantini, G; De Souza, C; Aversa, S; Patti, C; Tedeschi, L; Candela, M; Olivieri, A; Chisesi, T; Rubagotti, A; Centurioni, R; Nardi, V; Congiu, M; Gennaro, M; Truini, M-Artigo de periódico